Medicine & Health

Nancy Morrow-Howell, the Betty Bofinger Brown Distinguished Professor of Social Policy at the Brown School and director of the Harvey A. Friedman Center for Aging in the Institute for Public Health, is the recipient of the 2022 Maxwell A. Pollack Award for Contributions to Health Aging from the Gerontological Society of America.

Todd Braver, a professor of psychological and brain sciences in Arts & Sciences, received a $442,135 grant from the National Institutes of Health (NIH) to study aging effects on the neural coding of proactive and reactive cognitive control.

Research from the lab of Patrick Hill in psychological and brain sciences in Arts & Sciences shows a link in older adults between social interactions and having a sense of purpose.

The National Institutes of Health (NIH) awarded funding to Tammy English and Renee Thompson in Arts & Sciences for research to better understand emotion and aging.

Funded by a $33.1 million grant from the National Institute on Aging, researchers from the School of Medicine and other institutions have launched a large study that investigates just what keeps our brains sharp as we age and what contributes to cognitive decline.

The National Institute on Aging of the National Institutes of Health (NIH) has awarded researchers at Washington University School of Medicine a five-year $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic’s cognitive and emotional effects on older adults.

Washington University School of Medicine in St. Louis has joined the NIH’s SenNet, a national research network focused on understanding senescent cells, an elusive but important cell type that plays key roles in the diseases of aging.

New research from Washington University School of Medicine suggests that in-home falls can be reduced by nearly 40% with a community-based program that helps older adults make modifications to their homes to prevent such mishaps.

Washington University’s Meredith Jackrel and Jai Rudra and are researching nanofiber materials that will eliminate the need for vaccine adjuvants.

In the first clinical trial of nicotinamide mononucleotide (NMN), School of Medicine researchers have found that the compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice also has clinically relevant effects in people.